Treatment of kaempferol, which was administered exogenously to pancreatic cancer cells, significantly decreased the phosphoylation levels of EGFR, Src, AKT, and ERK1/2 in a time-dependent manner in Miapaca-2 and Panc-1 cells (Fig 5A). This evidence concerns the gene SRC and familial pancreatic carcinoma.